In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

What's Fueling The Recent Diagnostics Dealmaking?

Executive Summary

A variety of new players have become active dealmakers around personalized medicine diagnostics tests and services. One way to put these deals in context is to view the acquired assets through the lens of how they are to be deployed. To a large extent, the transactions are being driven by the interests of drugmakers, which are seeking new tools to assist them in clinical trials, thus creating more opportunity for the acquirers to offer clinical development services.
Advertisement

Related Content

Medical Device and In Vitro Diagnostics/Research Deals Statistics Quarterly, Q2 2011
Is Diagnostics the New Biotech...and Will Pharma Embrace It?
Delivering Cancer Diagnostics Tools
With Genoptix, Novartis Continues Its Diagnostics Build-up
GE Acquires Clarient To Anchor Its Molecular IVD Business
GE Acquires Clarient To Anchor Its Molecular IVD Business
Taking Stock Of Qiagen
Taking Stock Of Qiagen
Novartis Follows Its Own Business Development Model into Molecular Diagnostics
The Pace of Development of Molecular Imaging Agents

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV003631

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel